SCHEMBL4400577

SCHEMBL4400577

CC(C)COc1ccc([O])cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.47
HPGD P15428 3/20 0.47
POLB P06746 2/20 0.47
XBP1 P17861 1/20 0.47
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ACACB O00763 5/20 0.45
NPC1 O15118 3/20 0.45
LMNA P02545 3/20 0.45
TSHR P16473 2/20 0.45
RAB9A P51151 2/20 0.45
HSD17B10 Q99714 1/20 0.45
NR1H4 Q96RI1 2/20 0.44
MEN1 O00255 1/20 0.44
ALOX12 P18054 1/20 0.44
KMT2A Q03164 1/20 0.44
XDH P47989 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL123415 0.88 MAPT (0.55) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL20851318 0.81 MAPT (0.58) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL8765745 0.79 FFAR1 (0.39) MAPTPOLBLMNANPSR1
SCHEMBL3182331 0.79 HPGD (0.66) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL2231003 0.79 TSHR (0.50) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL7329813 0.79 NQO1 (0.67) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL6539450 0.78 ACACB (0.50) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL8048419 0.78 MAPT (0.49) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL8047267 0.78 ACACB (0.50) MAPTHPGDPOLBXBP1ALDH1A1
SCHEMBL4397519 0.78 NQO1 (0.41) MAPTPOLBALDH1A1CYP2C9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111315828-B Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2023-09-29 CN disclosed
CN-112154167-B Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2023-08-22 CN disclosed
CN-112154167-A Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2020-12-29 CN disclosed
CN-111315828-A Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2020-06-19 CN disclosed
WO-2020071470-A1 PHTHALOCYANINE COMPOUND AND USE THEREOF 山本化成株式会社 2020-04-09 WO disclosed
WO-2020021969-A1 COMPOSITION, CURED PRODUCT, OPTICAL FILTER, AND PRODUCTION METHOD FOR CURED PRODUCT 株式会社ADEKA 2020-01-30 WO disclosed
US-20090306376-A1 OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME MITSUI CHEMICALS, INC. (JP) 2009-12-10 US disclosed
US-20070054084-A1 Optical recording medium and compound used for the same MITSUI CHEMICALS, INC. (JP) 2007-03-08 US disclosed
EP-1672626-A1 OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM Mitsui Chemicals, Inc. (JP) 2006-06-21 EP disclosed
US-20050222423-A1 Carboxylic acid derivative TAISHO PHARMECEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed
EP-1466891-A1 CARBOXYLIC ACID DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2004-10-13 EP disclosed
EP-0351615-B1 PROCESS FOR THE PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS BASF Aktiengesellschaft (DE) 1992-10-28 EP disclosed
US-5072034-A PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 1991-12-10 US disclosed
EP-0351615-A1 Process for the preparation of 4-alkoxy-2-hydroxybenzophenone-5-sulfonic acids BASF Aktiengesellschaft (DE) 1990-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222423-A1 Carboxylic acid derivative KDR, FLT1, FLT4 MAPT 4496/4885HPGD 1258/4885POLB 2281/4885
US-20090306376-A1 OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME CACNA1B, KCNN4, KCNN2 MAPT 415/4885HPGD 2788/4885POLB 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.